Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BCAB - Week In Review: MicroTech Medical Staging $245 Million HK IPO For Diabetes Products


BCAB - Week In Review: MicroTech Medical Staging $245 Million HK IPO For Diabetes Products

  • LianBio, a Princeton, NJ-Shanghai biopharma, has filed for a $100 million IPO on the NASDAQ exchange.
  • According to a Bloomberg article, I-Mab is in wide-ranging discussions with US and EU biopharmas for a deal that could out-license an I-Mab asset or involve a direct investment in the Shanghai biopharma.
  • Shanghai's Zai Lab reported its in-licensed HER2 drug met its endpoints in patients with previously treated HER2+ breast cancer.

For further details see:

Week In Review: MicroTech Medical Staging $245 Million HK IPO For Diabetes Products
Stock Information

Company Name: BioAtla Inc.
Stock Symbol: BCAB
Market: NASDAQ
Website: bioatla.com

Menu

BCAB BCAB Quote BCAB Short BCAB News BCAB Articles BCAB Message Board
Get BCAB Alerts

News, Short Squeeze, Breakout and More Instantly...